Infantile and preschool asthma
No Thumbnail Available
Date
2012
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
In infants and preschool children the symptoms suggestive of asthma (e.g. wheeze) may be a clinical expression of a number of diseases with different aetiologies. If this is true, then it is unlikely that these different diseases would respond to the same treatment. Consequently, implementation of a management strategy which is effective for each individual patient is challenging, and controversies remain with respect to which patients should be given anti-asthma treatment, and when the treatment should be started and for how long. Whilst acknowledging these uncertainties, practicing physicians may use the Asthma Predictive Index (API) as a guide in clinical practice to identify young children with recurrent wheezing who are at risk of the subsequent development of persistent asthma, and who may benefit from preventative anti-asthma medication. We acknowledge that a number of questions on the most appropriate management strategy remain unanswered, including which type of medication is the best for individual patients (e.g. short-acting beta-agonist versus inhaled corticosteroid (ICS) versus leukotriene receptor antagonist (LTRA)), dose (high versus low) and schedule (regular versus as needed).